Folic acid supplementation modifies β-adrenoceptor-mediated in vitro lipolysis of obese/diabetic (+db/+db) mice

Experimental Biology and Medicine

Volumn 234, Issue 9, 2009, Pages 1047-1055

  Lam, Tsz Yan ^a   Seto, Sai Wang ^a   Au, Alice Lai Shan ^a   Poon, Christina Chui Wa ^a   Li, Rachel Wai Sum ^a   Lam, Ho Yeung ^a   Lau, Wing Sze ^a   Chan, Shun Wan ^b   Ngai, Sai Ming ^c   Leung, George Pak Heng ^a   Lee, Simon Ming Yuen ^d   Tsui, Stephen Kwok Wing ^a,e   Kwan, Yiu Wa ^a,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d University of Macau   (Macao)

^e and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

adrenoceptor; +db +db mice; Adipocytes; Folic acid; Lipolysis

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 8 BROMO CYCLIC AMP; ADRENALIN; BETA ADRENERGIC RECEPTOR; FOLIC ACID; FORSKOLIN; HOMOCYSTEINE; SALBUTAMOL; YOHIMBINE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG INHIBITION; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; IN VITRO STUDY; LIPOLYSIS; LOW DRUG DOSE; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SUPPLEMENTATION;

ADIPOCYTES; ANIMALS; CELLS, CULTURED; FEMALE; FOLIC ACID; LIPOLYSIS; MICE; RECEPTORS, ADRENERGIC; RECEPTORS, LEPTIN; VITAMINS;

MUS;

EID: 70349094101     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0902-RM-44     Document Type: Article

References (33)

1. Frayn KN. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64:7-13, 2005.
2. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of β2-adrenoceptors. Diabetologia 37:428-435, 1994. (Pubitemid 24113577)
3. Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signalling 18:401-408, 2006.
4. 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. Curr Pharm Des 7:1433-1449, 2001.
5. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53:482-491, 2006. (Pubitemid 43767551)
6. 3-adrenergic receptor activation on the type 2 diabetic MKR mice. Am J Physiol 290:E1227-E1236, 2006.
7. 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20:191-199, 1996.
8. Hashimoto K, Nagao Y, Ida K, Takeda M, Murakami N, Kato K, Mizota M. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2-(3- chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents. Biochem Pharmacol 52:1529-1535, 1996. (Pubitemid 26375458)
9. Ntaios GC, Savopoulos CG, Chatzinikolaou AC, Kaiafa GD, Hatzitolios A. Vitamins and stroke: the homocysteine hypothesis still in doubt. Neurologist 14:2-4, 2008.
10. Stanger O, Semmelrock HJ, Wonisch W, Bos U, Pabst E, Wascher TC. Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects. J Pharmacol Exp Ther 303:158-162, 2002. (Pubitemid 35056463)
11. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C, Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 34:2002-2006, 1999. (Pubitemid 30002657)
12. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arter Thromb Vasc Biol 18:133-138, 1998. (Pubitemid 28047610)
13. Bunout D, Garrido A, Suazo M, Kauffman R, Venegas P, de la Maza P, Petermann M, Hirsch S. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition 16:107-110, 2000. (Pubitemid 30103711)
14. Clarke ZL, Moat SJ, Miller AL, Randall MD, Lewis MJ, Lang D. Differential effects of low and high dose folic acid on endothelial dysfunction in a murine model of mild hyperhomocysteinaemia. Eur J Pharmacol 551:92-97, 2006. (Pubitemid 44648062)
15. van Etten RW, de Koning EJ, Verhaar MC, Gaillard CA, Rabelink TJ. Impaired NO-dependent vasodilation in patients with type II (non-insulin- dependent) diabetes mellitus is restored by acute administration of folate. Diabetologia 45:1004-1010, 2002.
16. Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ, Taylor PR. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr 62:644-650, 2008. (Pubitemid 351663404)
17. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846, 2006. (Pubitemid 46024990)
18. Mural RJ et al. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science 296:1661-1671, 2002.
19. Seto SW, Lam TY, Leung GPH, Au ALS, Ngai SM, Chan SW, Kwan YW. Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-gamma activation in +db/+m and +db/+db mice. Eur J Pharmacol 572:40-48, 2007.
20. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43-52, 1987. (Pubitemid 17167357)
21. Morita H, Saito Y, Ohashi N, Yoshikawa M, Katoh M, Ashida T, Kurihara H, Nakamura T, Kurabayashi M, Nagai R. Fluvastatin ameliorates the hyperhomocysteinemia-induced endothelial dysfunction: the antioxidative properties of fluvastatin. Circ J 69:475-480, 2005. (Pubitemid 40502343)
22. Mullick AE, Zaid UB, Athanassious CN, Lentz SR, Rutledge JC, Symons JD. Hyperhomocysteinemia increases arterial permeability and stiffness in mice. Am J Physiol 291:R1349-R1354, 2006. (Pubitemid 44776710)
23. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964.
24. Harikai N, Hashimoto A, Semma M, Ichikawa A. Characteristics of lipolysis in white adipose tissues of SHR/NDmc-cp rats, a model of metabolic syndrome. Metabolism 56:847-855, 2007. (Pubitemid 46734092)
25. 3- adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes. Nitric Oxide 14:200-211, 2006.
26. 2- adrenoceptor expression in fat cells. J Clin Invest 90:2175-2186, 1992.
27. 3-adrenergic agonist-stimulated lipolytic response in hyperthyroid and hypothyroid rat white adipocytes. Br J Pharmacol 129:448-456, 2000.
28. Germack R, Starzec AB, Vassy R, Perret GY. β-adrenoceptor subtype expression and function in rat white adipocytes. Br J Pharmacol 120:201-210, 1997. (Pubitemid 27039267)
29. 2A-adrenoceptor and phosphodiesterase-3B in human adipocytes of different origin. Int J Obes (Lond) 29:1413-1421, 2005.
30. Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endoc Metab 19:471-482, 2005. (Pubitemid 41819214)
31. Dimon-Gadal S, Gerbaud P, Keryer G, Anderson W, Evain-Brion D, Raynaud F. In vitro effects of oxygen-derived free radicals on type I and type II cAMP-dependent protein kinases. J Biol Chem 273:22833-22840, 1998.
32. Raynaud F, Evain-Brion D, Gerbaud P, Marciano D, Gorin I, Liapi C, Anderson WB. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis. Free Rad Biol Med 22:623-632, 1997. (Pubitemid 27043399)
33. Racek J, Rusnakova H, Trefil L, Siala KK. The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Res 54:87-95, 2005. (Pubitemid 40363658)